Skip to main content
. 2022 Dec 2;10(9):940–957. doi: 10.1002/ueg2.12313
Recommendation 5.29

  • Rifaximin cannot be recommended for the treatment of chronic uncomplicated diverticular disease.

  • Evidence level 2, recommendation grade 0, strong consensus